The study’s limitation was that the sample size was too small to draw any firm conclusions about the association between ACPA seropositivity, DRB1*04 or *10 allele frequency, and changes in hematological and biochemical markers. More research with bigger samples is needed to determine these associations in other kinds of Sudanese RA patients with different symptoms. This evidence concerns the gene PRTN3 and rheumatoid arthritis.